Abstract Infections are common in people with dementia, and antibiotic use is widespread, albeit highly variable, across healthcare settings and countries. The few studies conducted to date that consider the appropriateness of antibiotic prescribing specifically for people with dementia focus on people with advanced dementia and suggest that much of the prescribing of antibiotics for these patients may be potentially inappropriate. We suggest that clinicians must consider a number of factors to determine appropriateness of antimicrobial prescribing for people with dementia, including the risks and benefits of assessing and treating infections, the uncertainty regarding the effects of antibiotics on patient comfort, goals of care and treatment preferences, hydration status, dementia severity and patient prognosis. Future research should examine antibiotic prescribing and its appropriateness across the spectrum of common infections, dementia severities, care settings and countries, and should consider how antibiotic therapy should be considered in discussions regarding treatment preferences, goals of care and/or advance care planning between clinicians, patients and families.
Introduction
Dementia is an irreversible progressive neurodegenerative disorder in which widespread neuronal cell death results in decline across a range of cognitive domains, including memory difficulties, language disturbances, psychosocial and psychiatric changes, loss of ability to recognise familiar people or common objects and impairment in activities of daily living [1] [2] [3] . It has been renamed 'major neurocognitive disorder' in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) [3] in an effort to reduce stigma associated with dementia, to bring diagnostic guidelines into line with current clinical practice and in recognition of earlier stages of cognitive decline as mild neurocognitive disorder (NCD) [4] .
Many aetiological variants of dementia exist, distinguished by unique neuropathology and determined by the area or structure within the brain predominantly affected [5] . Alzheimer's disease (AD) is the most common variant, followed by vascular dementia (VaD). There is considerable overlap between AD and VaD; the amyloid plaques and neurofibrillary tangles associated with AD often coexist with the multiple infarctions present in VaD, and, where this occurs, patients are diagnosed with mixed dementia [6, 7] . Though AD and VaD are the most common variants to co-exist in mixed dementia, the term may be used to refer to the presence of two or more of any of the aetiological variants of dementia. Dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD) are less common variants that account for much smaller percentages of diagnosed cases.
The World Alzheimer Report [8] published in 2015 estimated that 46.8 million people worldwide are living with dementia, and this number is expected to almost double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050. Infections, including respiratory tract infections (RTIs), urinary tract infections (UTIs) and skin and soft tissue infections [9, 10] , are common in people with dementia. Treatment decisions for these vulnerable patients are often highly complex, particularly as dementia progresses and patients approach end of life [11] , because patients are unable to communicate their symptoms as cognitive function declines and because typical symptoms of infections are often absent [12, 13] . Such decisions typically involve balancing the potential benefits and burdens of treatment, patient and family preferences, the best interests of the patient and the risk of developing antibiotic-resistant microbes [14] [15] [16] [17] . A recent systematic review by van der Maaden et al. [11] substantiated the view in the literature that decisions to start or withhold antibiotic treatment are challenging, identifying over 40 person-and context-related factors associated with antibiotic use in this population. The authors reported that these decisions are strongly influenced by country, healthcare context and family and physician preferences [11] .
The variability in antibiotic prescribing rates and practices across dementia severity, healthcare settings and countries may be due to the complexity of treatment decisions about antibiotics in dementia as well as limitations in certain care settings (such as the absence of diagnostic resources in long-term care environments) and a limited and somewhat contradictory evidence base on the effects of antibiotic use [11, 18, 19] . The objectives of this narrative review were to consider the most common infections in people with dementia and the treatment of such infections in this vulnerable patient group. We also consider the appropriate and inappropriate use of antimicrobials and the variations in prescribing and care, including at the end of life, with a particular focus on the long-term care setting to reflect the majority of the research literature in this area. Finally, we make recommendations for practice and highlight research priorities for future studies in this area.
Infections in Older People with Dementia
Immune senescence (age-associated changes in innate and adaptive immunity), frailty (defined as a state of increased vulnerability to poor resolution of homeostasis after a stressor event [20] ), and physiological changes such as decreased nutritional status, development of swallowing difficulties and reduced mucociliary clearance predispose older people to infection [21] [22] [23] . Furthermore, the aging process can complicate the diagnosis and treatment of infectious disease: fever and increased white cell counts tend to be less pronounced, which can lead to infections remaining undiagnosed [24] . Age-related pharmacokinetic changes can alter the absorption, distribution and elimination of antibiotics, rendering treatment less effective or increasing the risk of toxicity [25] [26] [27] . Consequently, older people are at increased risk of not only developing infections, including lower respiratory tract infections (LRTIs; pneumonia), UTIs, and skin and soft tissue infections, but also experiencing misdiagnosis and mismanagement [23] . Diagnosis is further complicated by difficulties obtaining good-quality uncontaminated clinical specimens from older people, particularly from those who are unable to comply with the directions for obtaining such a sample. Although the risk of developing pneumonia is not significantly higher for people with dementia than for cognitively intact frail older people [28] [29] [30] , diagnosis is more difficult, particularly in the more advanced stages of dementia, and risks of misdiagnosis and mismanagement are further increased. These individuals are more likely to experience a delay in recognising changes in status that would prompt assessment for infection and have an increased risk of mortality, both in general [31, 32] and due to an infection [33] [34] [35] [36] . A systematic review and meta-analysis to determine whether people with dementia were more likely to die from pneumonia as the immediate or underlying cause reported that the odds of pneumonia-associated mortality were increased more than twofold for people with dementia [33] . Dysphagia has been recognised as a risk factor for pneumonia in people with dementia [37] , and pneumonia and intake problems are important risk factors for mortality across all stages of dementia [9, 38] . Studies focusing on advanced dementia have reported an association between dysphagia and aspiration pneumonia [39] and demonstrated that pneumonia is significantly associated with shortened survival in nursing home residents [34, 40] . It has been suggested that the increased mortality with pneumonia in advanced dementia is associated with aspiration and weight loss [41] and with artificial feeding via the enteral route [42] .
Antibiotics are widely prescribed for older people with dementia; to date, most studies of the prevalence of antibiotic use have considered the long-term care setting, with a smaller number examining hospital or communitydwelling settings [11] . These studies assessed the prevalence of antibiotic use in a variety of ways, including point prevalence, period prevalence, antibiotic use in the last period before death and antibiotic use during a specific infectious episode. The authors acknowledged the range of methods used in the included studies and reported that antibiotic use for people with dementia is often substantial but varies widely across healthcare contexts and countries. Point prevalence ranged from 3.3 to 16.6%, with period prevalence ranging from 4.4 to 88% overall and from 23.5 to 94% in variable timeframes before death. The median use was reported to be 52% for a median period of 14 days and 48% for a median period of 22 days. Antibiotics were prescribed for most patients with LRTIs or UTIs, with 77-91% of patients receiving treatment. The authors also found that more severe dementia was associated with lower rates of antibiotic use [11] . Poor prognosis was also associated with antibiotic use, and the direction of this association was dependent on the country of care. Patients with a poor prognosis were more likely to receive antibiotics in studies conducted in the USA [43, 44] and across seven European countries and Israel [45] . Conversely, people with a poor prognosis were more likely to not be prescribed antibiotics in The Netherlands [44] .
Appropriateness of Antibiotic Use
In considering antimicrobial prescribing for people with dementia, it is important to examine not only the prevalence of such prescribing but also whether it is appropriate. Prescribing is considered to be appropriate when medicines have a clear evidence-based indication and are cost effective and well-tolerated [46] . Terms such as 'inappropriate medication use', 'inappropriate drug use' (IDU), 'inappropriate prescribing' (IP) and 'potentially inappropriate prescribing' (PIP) are used throughout the literature to refer to suboptimal prescribing practices, which include misprescribing, overprescribing and underprescribing of medications [47, 48] . A significant body of research has examined the appropriateness of antimicrobial use in older people residing in long-term care settings; however, work examining the appropriateness of antibiotic prescribing specifically in people with dementia has thus far been limited [49, 50] .
The few studies conducted to date that do consider appropriateness of antibiotic use in people with dementia focussed on the advanced stages of disease; one study of US nursing home residents reported that 44% of suspected infectious episodes for which antimicrobials were prescribed met minimum clinical criteria [18] , suggesting that much of the prescribing of antibiotics in advanced dementia may be unwarranted [50] . The authors concluded that antibiotics were most likely to be initiated in the absence of minimum treatment criteria for UTIs, which rely on subjective signs and symptoms undetectable to the observer in the absence of patient self-report. They recognised that, while asymptomatic bacteriuria is the most common reason for potentially inappropriate antimicrobial prescribing in the nursing home setting, the interpretation of what is 'symptomatic' in people in advanced dementia, and therefore the application of minimum criteria for treatment, are particularly challenging [50] .
Recommendations for Clinical Practice
In clinical practice, a number of factors must be taken into account when considering the appropriateness of antimicrobial treatment for this vulnerable patient group. Consideration should not be limited to whether treatment should be initiated. Further aspects that must be considered include whether a particular medication should be chosen based on the infection being treated and local antimicrobial susceptibility and resistance patterns; whether treatment should be changed or continued based on clinical response or culture and diagnostic testing results; treatment length; administration route (oral vs. intravenous); and the wishes and preferences of the patient and their family.
Clinicians must take into account many factors when making decisions regarding antimicrobial prescribing for people with dementia. First, antibiotic therapy in the terminal stages of dementia prolongs survival in very few patients; indeed, it has been argued that it may simply prolong the dying process [51, 52] . Second, whether antibiotics play a significant role in the maintenance of comfort in people with dementia and pneumonia is unclear. A study of 323 nursing home residents with advanced dementia in 22 US nursing homes considered symptoms before, during and after pneumonia and reported that treatment with antimicrobial agents did not improve the comfort (symptom burden) of residents with advanced dementia and pneumonia. It is important to note that, in this study, comfort was assessed on one occasion during a 3-month period that included the episode of pneumonia [53] . In contrast to the work by Volicer and Simard [51] and van der Steen et al. [52] , Givens et al. [53] also reported prolonged survival among patients who received antibiotics compared with those who did not.
Others have argued that antibiotic treatment is associated with improved comfort [54] , and more recent work suggests that antibiotics may not make a difference in comfort levels if effective symptom relief is provided [55] . Antibiotics may be prescribed because physicians and family members believe that antibiotics improve patient comfort [56, 57] . Further, antibiotic use may be associated with significant adverse effects, such as gastrointestinal upset, allergic reactions, hyperkalemia and, rarely, agranulocytosis; overuse may lead to Clostridium difficile infection and the development of antimicrobial resistance to treatment [51] .
A decision to treat a patient with signs and symptoms suggestive of infection may not necessarily require the prescribing of antibiotic therapy. Such a decision may be made in the context of goals of care or may be based on a conservative therapeutic approach involving watchful waiting and may therefore be revisited as a patient is offered symptomatic relief and supportive care, including pain management, skin care and hydration. The interplay of the factors outlined above complicates the clinical decision-making process regarding the appropriateness of antimicrobial therapy for this patient group. Decisions to prescribe or withhold antibiotics in advanced stages should consider the risks and benefits of assessing and treating infections and the uncertainty regarding any significant benefits of treatment for patient comfort and should align such considerations with goals of care [50, 51] . If a decision is reached to withhold antibiotics, suspected infections should not be worked up and symptoms should be treated using palliative measures alone [50] .
Furthermore, clinicians must also bear in mind the hydration status of the patient because of its impact on the effectiveness of antibiotic therapy. Similar mortality rates have been reported for nursing home residents who had sufficient water intake whether or not they were prescribed antibiotics [51, 52, 58] . Conversely, a twocountry study found that antibiotics were less effective in nursing home residents with insufficient water intake and reported that mortality rates were highest for residents who neither received antibiotics nor had sufficient water intake [58] .
Optimising the management of infections in people with dementia is of critical importance and requires collaboration between geriatrics and infectious disease specialists and, in the more advanced stages of dementia, palliative care experts [59] . It should include patient and family counselling, clinical training and the development and/or utilisation of clinical algorithms to evaluate appropriateness of antimicrobial prescribing that consider dementia severity, patient prognosis, goals and burden of care and treatment preferences as appropriate [17, [59] [60] [61] .
Research Priorities
To date, studies considering the prevalence of antibiotic use in people with dementia have focused on people with advanced stages of the disease residing in long-term care or hospital settings and have not considered common infections such as skin or soft tissue infections [11] . Further work examining antibiotic prescribing across the spectrum of common infections (UTIs, LRTIs and skin and soft tissue infections), dementia severities and care settings (long-term care, hospital and community) is therefore a research priority.
Studies examining the appropriateness of antibiotic prescribing for older people in nursing homes have used a number of different algorithms [62] ; it has been suggested that a universally applicable instrument that accounts for country-specific practice variations to facilitate international comparison should be developed, into which existing guidelines and articles on appropriate prescribing of antibiotics [63] [64] [65] [66] [67] [68] and patient preference and prognosis [62] could be incorporated. Whilst these guidelines are not specific to people with dementia, it has been argued that, in developing such an instrument, applicability should be ensured across long-term care facilities and countries as well as in residents of such facilities with dementia [13] . Future research should therefore focus on the development of such an instrument and should consider discussions between clinicians, patients and families regarding antibiotic treatment preferences, goals of care and/or advance care planning. There is also a need to define appropriate outcomes to be employed in randomised controlled trials of antimicrobials in people with dementia, particularly in relation to (dis)comfort measures.
Conclusion
Infections are common among people with dementia, and the prescribing of antibiotics is prevalent, albeit highly variable across settings of care and across countries. The appropriateness of such prescribing has been neglected in the research literature to date. Further studies into the prevalence and appropriateness of antibiotic prescribing across the spectrum of common infections, dementia severities, care settings and countries is a research priority. 
